Note 3 - Stock-based Compensation

6 Months Ended

Dec. 30, 2018

Notes to Financial Statements

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note

3

– Stock-Based Compensation

The Company has a Long Term Incentive and Share Award Plan, which is more fully described in Note

12

and Note

13

to the consolidated financial statements included in the Company’s Annual Report on Form

10

-K for the fiscal year ended

July 1, 2018,

that provides for the grant to eligible employees, consultants and directors of stock options, restricted shares, and other stock-based awards.

The amounts of stock-based compensation expense recognized in the periods presented are as follows:

	Three Months Ended				Six Months Ended
	December 30, 2018		December 31, 2017		December 30, 2018		December 31, 2017
			(in thousands)
Stock options	$	78	$	107	$	183	$	215
Restricted stock		1,595		861		2,445		1,854
Total		1,673		968		2,628		2,069
Deferred income tax benefit		395		206		654		592
Stock-based compensation expense, net	$	1,278	$	762	$	1,974	$	1,477

 Stock-based compensation is recorded within the following line items of operating expenses:

	Three Months Ended				Six Months Ended
	December 30, 2018		December 31, 2017		December 30, 2018		December 31, 2017
			(in thousands)
Marketing and sales	$	731	$	258	$	986	$	556
Technology and development		105		51		156		111
General and administrative		837		659		1,486		1,402
Total	$	1,673	$	968	$	2,628	$	2,069

Stock based compensation expense has

not

been allocated between business segments, but is reflected as part of Corporate overhead. (see 

Note

12

- Business Segments

.)

Stock Options

The following table summarizes stock option activity during the 

six

months ended

December 30, 2018:

	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value (000s)
Outstanding at July 1, 2018		1,968,234		$	2.35
Granted		-		$	-
Exercised		(268,234	)	$	2.33
Forfeited		-		$	-
Outstanding at December 30, 2018		1,700,000		$	2.35		2.4	$	16,265
Exercisable at December 30, 2018		1,562,000		$	2.27		2.4	$	15,068

As of

December 30, 2018,

the total future compensation cost related to non-vested options,

not

yet recognized in the statement of income, was

$0.2

million and the weighted average period over which these awards are expected to be recognized was

0.9

 years.

Restricted Stock

The Company grants shares of Common Stock to its employees that are subject to restrictions on transfer and risk of forfeiture until fulfillment of applicable service and performance conditions and, in certain cases, holding periods (Restricted Stock). The following table summarizes the activity of non-vested restricted stock awards during the

six

months ended

December 30, 2018:

	Shares			Weighted Average Grant Date Fair Value
Non-vested at July 1, 2018		968,273		$	7.70
Granted		911,089		$	12.49
Vested		(409,676	)	$	7.90
Forfeited		(8,180	)	$	9.45
Non-vested at December 30, 2018		1,461,506		$	10.62

The fair value of non-vested shares is determined based on the closing stock price on the grant date. As of

December 30, 2018,

there was

$13.2

 million of total unrecognized compensation cost related to non-vested restricted stock-based compensation to be recognized over the weighted-average remaining period of

2.3

 years.